Paris, France · Founded 2010 · Privately Held (backing)
Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation. HighLife is based in Paris, France and was founded in 2010. It was valued at $534 million at its later-stage round in Sep 2026, the last priced event on record. It has raised $71 million across 1 recorded round; the latest was a $90 million later-stage round in Sep 2026.
PMV mark · valuation
$534.1M
Oct 2026
Priced at
its later-stage round
Sep 2026
Total raised
$71.0M
Last round
Later Stage VC
Sep 2026
Cap table — not yet on record
HighLife's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of HighLife with a free account
·The post-money valuation on its round
·The complete investor list: 14 names
·Watch HighLife: the Monday email on marks, rounds and moves